TY - JOUR
T1 - Study Design of the Nationwide Japanese Lead Extraction (J-LEX) Registry
T2 - Protocol for a Prospective, Multicenter, Open Registry
AU - the J-LEX registry investigators
AU - Shoda, Morio
AU - Kusano, Kengo
AU - Goya, Masahiko
AU - Nishii, Nobuhiro
AU - Imai, Katsuhiko
AU - Okamoto, Yoji
AU - Takegami, Misa
AU - Nakao, Yoko M.
AU - Miyamoto, Yoshihiro
AU - Nogami, Akihiko
N1 - Funding Information:
Morio Shoda: Speaker honorarium from Medtronic Japan, and financial endowments to our clinical research division from Biotronik Japan, Medtronic Japan, Boston Scientific Japan, and Abbott Japan. Kengo Kusano: Speaker honoraria from DAIICHI SANKYO COMPANY, Ltd., Japan, Bristol‐Myers Squibb, Biotronik Japan, and Medtronic Japan, and research grants from Medtronic Japan and EP‐CRSU Co., Ltd. Masahiko Goya: Speaker hororarium from Japan Lifeline, Medtronic Japan, Johnson and Johnson, and Bayer. Nobuhiro Nishii: Speaker honoraria from Medtronic Japan, Boston Scientific Japan, and financial endowments to our clinical research division from Medtronic Japan. Akihiko Nogami: Speaker honoraria from Abbott and Daiichi‐Sankyo; an endowment from Medtronic and DVX.
Publisher Copyright:
© 2020 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Heart Rhythm Society.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Background: Transvenous lead extractions (TLEs) in Japan have grown to become the standard therapy since the approval of the laser extraction system in 2008. However, little is known about the current indications, methods, success rate, and acute complications in the real-world setting. Methods: The Japanese Lead EXtraction (J-LEX) registry is a nationwide, multicenter, observational registry, performed by the Japanese Heart Rhythm Society (JHRS) in collaboration with the National Cerebral and Cardiovascular Center. This study is a nationwide registry ordered by the JHRS and its data are collected prospectively using the Research Electronic Data Capture (REDCap) system. The acute success rate at discharge and complications associated with TLEs will be collected in all cases. Based on the provided information, the annual incidence and predictive factors for the outcomes will be investigated by the Event Assessment Committee (EAC). This registry started in July 2018 and the number of participating medical institutions will be more than 50 hospitals and the target number of procedures will be 500-1000 per year. We will also compare the results with other registries in foreign countries. Result: The results of this study are currently under investigation. Conclusion: The J-LEX registry will provide real-world data regarding the results and complications of TLEs for the various types of indications, methods, and performing hospitals in Japan.
AB - Background: Transvenous lead extractions (TLEs) in Japan have grown to become the standard therapy since the approval of the laser extraction system in 2008. However, little is known about the current indications, methods, success rate, and acute complications in the real-world setting. Methods: The Japanese Lead EXtraction (J-LEX) registry is a nationwide, multicenter, observational registry, performed by the Japanese Heart Rhythm Society (JHRS) in collaboration with the National Cerebral and Cardiovascular Center. This study is a nationwide registry ordered by the JHRS and its data are collected prospectively using the Research Electronic Data Capture (REDCap) system. The acute success rate at discharge and complications associated with TLEs will be collected in all cases. Based on the provided information, the annual incidence and predictive factors for the outcomes will be investigated by the Event Assessment Committee (EAC). This registry started in July 2018 and the number of participating medical institutions will be more than 50 hospitals and the target number of procedures will be 500-1000 per year. We will also compare the results with other registries in foreign countries. Result: The results of this study are currently under investigation. Conclusion: The J-LEX registry will provide real-world data regarding the results and complications of TLEs for the various types of indications, methods, and performing hospitals in Japan.
KW - J-LEX
KW - REDCap
KW - cardiac implantable electronic device
KW - complication
KW - lead extraction
UR - http://www.scopus.com/inward/record.url?scp=85087713114&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087713114&partnerID=8YFLogxK
U2 - 10.1002/joa3.12396
DO - 10.1002/joa3.12396
M3 - Article
AN - SCOPUS:85087713114
SN - 1880-4276
VL - 36
SP - 849
EP - 853
JO - journal of arrhythmia
JF - journal of arrhythmia
IS - 5
ER -